Figs Inc.

The company earns money by selling apparel outright to individual buyers, institutional customers, and retail-store shoppers, recognizing each sale once goods leave its control, rather than through subscriptions, licensing, or recurring service fees. Measured this way, the business has recently converted those sales into positive accounting profit across multiple consecutive fiscal years, after at least one earlier year on file when it did not.

Based on its channels and its balance sheet, the company appears to scale mainly by growing sales through its own website and app, which can reach more buyers without adding capacity in step, while its physical footprint, including its fulfillment operations and retail locations, expands one site at a time. It generates free cash flow at a level that is high relative to both its asset base and its equity base, and holds more cash and equity relative to its size than is typical for companies with this kind of production structure, with comparatively little debt, so its physical growth does not appear to depend on outside borrowing. By its own account, that growth can still be slowed by how much facility space, skilled staff, supplier capacity and accurate demand forecasting it has in place.

The company depends on a small set of overseas fabric suppliers concentrated in China, on contract manufacturers based mainly in Vietnam and Jordan, on the single fulfillment center it operates, and on an outside logistics partner. It also depends on outside platforms it does not control, including Instagram, search engines, other social media, and the app-store terms governing its iOS app, which it describes as largely non-negotiable, plus outside cloud and technology providers. It has a named partnership with New Balance covering part of its footwear line.

A wide range of individual healthcare professionals, from nurses to surgeons to veterinarians, along with institutional departments, medical offices and concierge clinics that buy through its institutional channel, depend on the company as a source of their professional apparel.

The company names its own product-design process built around healthcare professionals, its brand image, its digitally native direct-to-consumer approach, its purpose-built retail locations and its community-based marketing as what it considers its advantages over other apparel sellers, and separately describes itself as the largest direct-to-consumer platform in healthcare apparel and as the category-defining brand in that space, without citing a comparative market-share figure to support that description. This is the company's own account of its position, not an independent test of whether rivals could reproduce it. CompanyGraph maps the company as sharing its broader production-and-conversion structure with a number of other companies, so at that general level this combination of outsourced production with in-house design and distribution is not structurally rare, even though nothing here shows how easily a specific rival could assemble the same combination.

By its own account, the company's growth is limited by how much suitable facility space it can secure, how much skilled staff it can hire, how much manufacturing and sourcing capacity its outside partners can provide, how much fulfillment infrastructure it operates, and how accurately it can forecast demand. This is the company's own description of what constrains it, not an independent measurement, and it centers on capacity held by outside partners as much as on capacity it holds itself.

The company names several single points of dependence that could disrupt it: a concentrated base of fabric suppliers in China, a single fulfillment center that handles its shipments, an outside logistics operator, and outside app-store, search and social-media platforms it relies on for sales and traffic but does not control. It also names trade and forced-labor import restrictions tied to cotton and apparel sourcing from Asia as a specific risk to that supply chain.

The company operates under consumer-protection, labeling and import regulators in both the United States and Canada, and names exposure to tariffs, sanctions, customs rules and forced-labor import restrictions tied to the cotton and apparel supply chain, particularly around its Asia-based sourcing. It has not hedged its foreign-currency exposure from its Canadian operations. It also discloses unresolved securities and related shareholder litigation working through the appeals process.